Ongoing trials test COVID-19 drugs for earlier, easier treatment

At the COVID-19 Clinical Research Center on the Fred Hutch campus, people who recently received a positive test for SARS-CoV-2 are enrolled in trials of injectable antibodies and experimental antiviral drugs to see if these interventions may reduce the severity of symptoms and keep at risk patients out of the hospital.

Related Keywords

Fred Hutch ,Adrienne Shapiro ,Glaxosmithkline ,Hutch South Lake Union ,Clinical Research Center ,Research Center ,South Lake Union ,Mill Creek ,Vir Biotechnology ,Antiviral Drugs ,Iccrc ,Covid 19 ,Covid Positive Participants ,Elizabeth Duke ,Monoclonal Antibodies ,Clinical Research ,Antiviral ,Vaccine And Infectious Disease ,Covid 19 Crc ,Rachel Bender Ignacio ,